Context Therapeutics Inc banner

Context Therapeutics Inc
NASDAQ:CNTX

Watchlist Manager
Context Therapeutics Inc Logo
Context Therapeutics Inc
NASDAQ:CNTX
Watchlist
Price: 2.33 USD -3.32% Market Closed
Market Cap: $214.1m

Wall St Price Targets

CNTX Price Targets Summary
Context Therapeutics Inc

Wall Street analysts forecast CNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTX is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

Lowest Forecast
Price Target
4.04 USD
73% Upside
Average Forecast
Price Target
6.12 USD
163% Upside
Highest Forecast
Price Target
9.45 USD
306% Upside
Context Therapeutics Inc Competitors:
Price Targets
SPRO
Spero Therapeutics Inc
63% Upside
GTES
Gates Industrial Corporation PLC
23% Upside
THFF
First Financial Corp
8% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CNTX's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CNTX is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett